Annual Operating Profit
-$16.81 M
+$6.28 M+27.21%
31 December 2023
Summary:
Akari Therapeutics annual operaing income is currently -$16.81 million, with the most recent change of +$6.28 million (+27.21%) on 31 December 2023. During the last 3 years, it has risen by +$1.18 million (+6.53%). AKTX annual operating profit is now -2021.97% below its all-time high of -$792.00 thousand, reached on 31 December 2010.AKTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$1.85 M
+$3.70 M+66.66%
01 September 2024
Summary:
Akari Therapeutics quarterly operating income is currently -$1.85 million, with the most recent change of +$3.70 million (+66.66%) on 01 September 2024. Over the past year, it has increased by +$655.00 thousand (+26.13%). AKTX quarterly operating profit is now -15533.33% below its all-time high of $12.00 thousand, reached on 31 March 2019.AKTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$18.49 M
+$655.00 K+3.42%
01 September 2024
Summary:
Akari Therapeutics TTM operating income is currently -$18.49 million, with the most recent change of +$655.00 thousand (+3.42%) on 01 September 2024. Over the past year, it has dropped by -$6.77 million (-57.78%). AKTX TTM operating profit is now -881.73% below its all-time high of -$1.88 million, reached on 31 March 2014.AKTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKTX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.2% | +26.1% | -57.8% |
| 3 y3 years | +6.5% | -26.6% | -1.4% |
| 5 y5 years | +28.4% | +40.6% | -26.2% |
AKTX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +27.2% | -26.6% | +69.1% | -100.7% | +3.4% |
| 5 y | 5 years | at high | +28.4% | -650.1% | +76.3% | -100.7% | +15.6% |
| alltime | all time | -2022.0% | +52.1% | <-9999.0% | +83.0% | -881.7% | +47.3% |
Akari Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.85 M(-66.7%) | -$18.49 M(-3.4%) |
| June 2024 | - | -$5.55 M(-7.2%) | -$19.14 M(+5.2%) |
| Mar 2024 | - | -$5.99 M(+17.7%) | -$18.20 M(+8.3%) |
| Dec 2023 | -$16.81 M(-27.2%) | -$5.09 M(+103.0%) | -$16.81 M(+43.4%) |
| Sept 2023 | - | -$2.51 M(-45.7%) | -$11.72 M(+27.2%) |
| June 2023 | - | -$4.62 M(+0.5%) | -$9.21 M(-11.5%) |
| Mar 2023 | - | -$4.59 M(-21.0%) | -$10.41 M(-43.4%) |
| Dec 2022 | -$23.09 M(+34.1%) | - | - |
| June 2022 | - | -$5.82 M(+10.9%) | -$18.40 M(+8.8%) |
| Mar 2022 | - | -$5.24 M(-10.7%) | -$16.91 M(-1.8%) |
| Dec 2021 | -$17.21 M(-4.3%) | -$5.87 M(+301.3%) | -$17.21 M(-5.6%) |
| Sept 2021 | - | -$1.46 M(-66.2%) | -$18.24 M(+7.1%) |
| June 2021 | - | -$4.33 M(-22.0%) | -$17.02 M(-8.5%) |
| Mar 2021 | - | -$5.55 M(-19.5%) | -$18.60 M(+3.5%) |
| Dec 2020 | -$17.98 M(+6.0%) | -$6.90 M(+2692.8%) | -$17.98 M(-4.9%) |
| Sept 2020 | - | -$246.90 K(-95.8%) | -$18.91 M(-13.2%) |
| June 2020 | - | -$5.91 M(+20.0%) | -$21.78 M(-0.5%) |
| Mar 2020 | - | -$4.93 M(-37.0%) | -$21.90 M(+29.1%) |
| Dec 2019 | -$16.96 M(-27.8%) | -$7.83 M(+151.1%) | -$16.96 M(+15.8%) |
| Sept 2019 | - | -$3.12 M(-48.3%) | -$14.65 M(-14.9%) |
| June 2019 | - | -$6.03 M(<-9900.0%) | -$17.22 M(-10.2%) |
| Mar 2019 | - | $12.00 K(-100.2%) | -$19.17 M(-18.4%) |
| Dec 2018 | -$23.49 M | -$5.52 M(-3.0%) | -$23.49 M(-18.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$5.69 M(-28.7%) | -$28.88 M(-9.0%) |
| June 2018 | - | -$7.98 M(+85.3%) | -$31.74 M(+2.0%) |
| Mar 2018 | - | -$4.31 M(-60.5%) | -$31.11 M(-11.3%) |
| Dec 2017 | -$35.08 M(+28.8%) | -$10.91 M(+27.7%) | -$35.08 M(+3.1%) |
| Sept 2017 | - | -$8.54 M(+16.2%) | -$34.03 M(+8.0%) |
| June 2017 | - | -$7.35 M(-11.3%) | -$31.51 M(-0.5%) |
| Mar 2017 | - | -$8.28 M(-15.9%) | -$31.68 M(+16.3%) |
| Dec 2016 | -$27.25 M(+141.1%) | -$9.85 M(+63.6%) | -$27.25 M(+25.7%) |
| Sept 2016 | - | -$6.02 M(-19.9%) | -$21.68 M(+10.0%) |
| June 2016 | - | -$7.52 M(+95.2%) | -$19.71 M(+46.0%) |
| Mar 2016 | - | -$3.85 M(-10.2%) | -$13.50 M(+19.4%) |
| Dec 2015 | -$11.30 M(+488.8%) | -$4.29 M(+6.1%) | -$11.30 M(+39.3%) |
| Sept 2015 | - | -$4.04 M(+208.2%) | -$8.12 M(+89.2%) |
| June 2015 | - | -$1.31 M(-20.7%) | -$4.29 M(-19.2%) |
| Mar 2015 | - | -$1.65 M(+49.7%) | -$5.31 M(-4.1%) |
| Dec 2014 | -$1.92 M(-46.8%) | -$1.11 M(+406.9%) | -$5.54 M(+24.9%) |
| Sept 2014 | - | -$218.00 K(-90.6%) | -$4.43 M(+5.2%) |
| June 2014 | - | -$2.33 M(+23.7%) | -$4.21 M(+123.7%) |
| Mar 2014 | - | -$1.88 M | -$1.88 M |
| Dec 2013 | -$3.61 M(-1.7%) | - | - |
| Dec 2012 | -$3.67 M(+63.2%) | - | - |
| Dec 2011 | -$2.25 M(+183.7%) | - | - |
| Dec 2010 | -$792.00 K | - | - |
FAQ
- What is Akari Therapeutics annual operaing income?
- What is the all time high annual operating profit for Akari Therapeutics?
- What is Akari Therapeutics annual operating profit year-on-year change?
- What is Akari Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Akari Therapeutics?
- What is Akari Therapeutics quarterly operating profit year-on-year change?
- What is Akari Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Akari Therapeutics?
- What is Akari Therapeutics TTM operating profit year-on-year change?
What is Akari Therapeutics annual operaing income?
The current annual operating profit of AKTX is -$16.81 M
What is the all time high annual operating profit for Akari Therapeutics?
Akari Therapeutics all-time high annual operaing income is -$792.00 K
What is Akari Therapeutics annual operating profit year-on-year change?
Over the past year, AKTX annual operaing income has changed by +$6.28 M (+27.21%)
What is Akari Therapeutics quarterly operating income?
The current quarterly operating profit of AKTX is -$1.85 M
What is the all time high quarterly operating profit for Akari Therapeutics?
Akari Therapeutics all-time high quarterly operating income is $12.00 K
What is Akari Therapeutics quarterly operating profit year-on-year change?
Over the past year, AKTX quarterly operating income has changed by +$655.00 K (+26.13%)
What is Akari Therapeutics TTM operating income?
The current TTM operating profit of AKTX is -$18.49 M
What is the all time high TTM operating profit for Akari Therapeutics?
Akari Therapeutics all-time high TTM operating income is -$1.88 M
What is Akari Therapeutics TTM operating profit year-on-year change?
Over the past year, AKTX TTM operating income has changed by -$6.77 M (-57.78%)